-transparent.png){kind=logo}
The gastric inhibitory effects of CM57755, a new histamine H2 receptor antagonist, have been compared in ten healthy male volunteers with the actions of an equal dose of cimetidine and with placebo. The inhibitory effect of CM57755 was virtually identical with, and not significantly different from the effects of cimetidine on nocturnal gastric secretion of acid, while neither drug influenced the secretion of pepsin. Neither drug, administered in the evening, influenced the intragastric pH and acidity during the following day, from breakfast onwards. The therapeutic impact of the new drug is likely to resemble that of cimetidine and clinical application will depend on the safety profile.
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
November 1994,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
January 1984,
European journal of clinical pharmacology,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
February 1994,
Pharmacology,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
June 1989,
Nihon Jinzo Gakkai shi,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
May 1975,
Gut,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
April 1982,
Agents and actions,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
May 1994,
Japanese journal of pharmacology,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
March 1977,
Ugeskrift for laeger,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
July 1982,
Pharmacological research communications,
J A Wilson, and
D Johnston, and
J Penston, and
K G Wormsley
May 1986,
Archives internationales de pharmacodynamie et de therapie,
